Atrial Electromechanical Interval in the Prediction of Recurrence of Atrial Fibrillation in Patients Undergoing Successful Electrical Cardioversion to Sinus Rhythm - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information
First Received Date ^†	January 6, 2009
Last Updated Date	January 6, 2009
Start Date ^†	August 2008
Current Primary Outcome Measures ^† (submitted: January 6, 2009)	Recurrence of Atrial Fibrillation [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Original Primary Outcome Measures ^†	Same as current
Change History	No Changes Posted
Current Secondary Outcome Measures ^†
Original Secondary Outcome Measures ^†

Descriptive Information
Brief Title ^†	Atrial Electromechanical Interval in the Prediction of Recurrence of Atrial Fibrillation in Patients Undergoing Successful Electrical Cardioversion to Sinus Rhythm
Official Title ^†	Atrial Electromechanical Interval in the Prediction of Recurrence of Atrial Fibrillation In Patients Undergoing Successful Electrical Cardioversion to Sinus Rhythm
Brief Summary	Atrial electromechanical interval will add incremental value in the prediction of recurrence of atrial fibrillation among patients who underwent successful direct current cardioversion for atrial fibrillation.
Detailed Description
Study Phase
Study Type ^†	Observational
Study Design ^†	Cohort, Prospective
Condition ^†	Atrial Fibrillation
Intervention ^†
Study Arms / Comparison Groups
Publications *
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status ^†	Recruiting
Estimated Enrollment ^†	130
Completion Date
Estimated Primary Completion Date	December 2010 (final data collection date for primary outcome measure)
Eligibility Criteria ^†	Inclusion Criteria: Age greater than or equal to 19 years of age History of atrial fibrillation with successful cardioversion to sinus rhythm Informed consent to participate in the study Exclusion Criteria: Failure of cardioversion to sinus rhythm Use of anti-arrythmic drug therapy Refusal to participate in the study
Gender	Both
Ages	19 Years and older
Accepts Healthy Volunteers	No
Contacts ^††
Location Countries ^†	United States
Expanded Access Status

Administrative Information
NCT ID ^†	NCT00818012
Responsible Party	Jason Go, MD, Creighton University
Secondary IDs ^††
Study Sponsor ^†	Creighton University
Collaborators ^††
Investigators ^†
Information Provided By	Creighton University
Verification Date	January 2009
^† Required WHO trial registration data element. ^†† WHO trial registration data element that is required only if it exists.